;Total Cost M CLP;Percentage Cost;DifferenceCosts;FIT;Colonoscopy;FIT Costs;Colonoscopy Costs;Stage I Costs;Stage II Costs;Stage III Costs;Stage IV Costs;Treatments;StageI;StageII;StageIII;StageIV;StageI%;StageII%;StageIII%;StageIV%;YearsGained;AsymptomaticTreatments;SymptomaticTreatments;Inverted Percentage Cost;Percentage Years;Inverted Percentage Years;Efficacy Ratio;Cancer Treatments
"Worse
Sensitivity
(0.73)";251006;0.9989493373661799;-264;1626396;101670;9538.0;42805.0;18361;46608;37917;95777;11915;2401;4127;3278;2109;20.15%;34.64%;27.51%;17.70%;12919.0;4270.0;7645.0;0.001050662633820143;0.9841547954597395;0.015845204540260505;15.081153578907;11915
"Normal
Sensitivity
(0.79)";251270;1.0;0;1626419;101796;9538.0;42855.0;18813;46053;38323;95688;11958;2460;4078;3313;2107;20.57%;34.10%;27.71%;17.62%;13127.0;4416.0;7542.0;0.0;1.0;0.0;;11958
"Improved
Sensitivity
(0.85)";250715;0.9977912205993553;-555;1626522;101961;9538.0;42927.0;19347;45702;38196;95005;11971;2530;4047;3302;2092;21.13%;33.81%;27.58%;17.48%;13593.0;4561.0;7410.0;0.002208779400644678;1.035499352479622;-0.035499352479622104;-16.071932067666367;11971
